中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 2
Feb.  2012
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2012  >  28(2): 139-143

In vitro study of hepatocyte growth factor in inducing Wharton′s jelly-derived mesenchymal stem cells into hepatocyte-like cells

  • Published Date: 2012-02-20
    Abstract
  • Objective To observe the capability of hepatocyte growth factor in inducing Wharton′s jelly-derived mesenchymal stem cells (WJMSCs) into hepatocyte-like cells.Methods Wharton′s jelly-derived mesenchymal stem cells were isolated from human umbilical cord.The phenotype of mesenchymal stem cells and telomerase activity were identified.Four groups were set up to investigate the capability of hepatocyte growth factor in inducing Wharton′s jelly-derived mesenchymal stem cells into hepatocyte-like cells {Group A: WJMSCs+HGF (20 ng/ml) ;Group B: WJMSCs+HGF (40 ng/ml) ;Group C: HL-7702 cell line and Group D: WJMSCs}, and evaluate preliminarily by detecting the relative gene expression quantity of AFP and ALB.Results The phenotype of Wharton′s jelly-derived mesenchymal stem cells was positive in CD73, CD90, CD105 and HLA-ABC, but it was negative in CD45 and HLA-DR.Telomerase activity of WJMSCs showed no significant difference compared with that of HeLa cells.The mRNA of AFP increased at the 7th day in group A and B, while it was lower in group A than that of group B (P<0.05) .They both showed much lower than that of group C (P<0.05) , while there was no significant difference at 21st and 42nd day in group C (P>0.05) .The mRNA of ALB increased at the 7th day in group A and B (P>0.05) , but they were both lower than that of group C (P<0.05) .At 21st day, ALB in group A and B showed no significant difference compared with that of group C (P>0.05) ;and it was higher in group A and B than that of group C at the 42nd day (P<0.05) .Conclusion Hepatocyte growth factor could induce Wharton′s jelly-derived mesenchymal stem cells into hepatocyte-like cells, and this effect is related to the concentration of hepatocyte growth factor in the culture medium.

     

    • FullText(HTML)
    • References(12)
  • [1]Chen MY, Lie PC, Li ZL, et al.Endothelial differentiation ofWharton’s jelly derived mesenchymal stem cells in compari-son with bone marrow-derived mesenchymal stem cells[J].Exp Hematol, 2009, 37 (5) :629-640.
    [2]Kerr JF, Wyllie AH, Currie AR, et al.Apoptosis:a basic bio-logical phenomenon with wide-ranging implications in tissuekinetics[J].Br J Cancer, 1972, 26 (4) :239-257.
    [3]Oh SH, Miyazaki M, Kouchi H, et al.Hepatocyte growthfactor induces differentiation of adult rat bone marrow cellsinto a hepatocyte lineage in vitro[J].Biochem Biophys ResCommun, 2000, 279 (2) :500-504.
    [4]Forte G, Minieri M, Cossa P, et al.Hepatocyte growth fac-tor effects on mesenchymal stem cells:proliferation, migra-tion, and differentiation[J].Stem Cells, 2006, 24 (1) :23-33.
    [5]李明月, 刘立忠, 黄尚志, 等.肝细胞生长因子抑制MRC-5成纤维细胞所致的纤维化作用[J].基础医学与临床, 2002, 22 (5) :422-427.
    [6]Bell A, Chen Q, De F, et al.The five amino acid-deletedisoform of hepatocyte growth factor promotes carcinogenesisin transgenic mice[J].Oncogene, 1999, 18 (4) :887-895.
    [7]Baldi A, Abbate A, Bussani R, et al.A poptosis and post-infarction left ventricular remodeling[J].J Mol Cell Cardiol, 2002, 34 (2) :165-174.
    [8]Lee KD, Kuo TK, Whang PJ, et al.In vitro hepatic differenti-ation of human mesenchymal stem cells[J].Hepatology, 2004, 40 (6) :1275-1284.
    [9]Lee KD.Applications of mesenchymal stem cells:an upda-ted review[J].Chang Gung Med J, 2008, 31 (3) :228-236.
    [10]Kang XQ, Zang WJ, Bao LJ, et al.Hepatocyte growth factorand fibroblast growth factor-4-induced differentiation ofhuman umbilical cord blood derived mesenchymalstem cellsinto hepatocytes[J].World J Gastroenterol, 2005, 11 (47) :7461-7465.
    [11]Wang PP, Wang JH, Yan ZP, et al.Expression of hepato-cyte-like phenotypes in bone marrow stromal cells afterHGF induction[J].Biochem Biophys Res Commun, 2004, 320 (3) :712-716.
    [12]Zhang GQ, Fang CH, Chi DZ.Hepatocyte growth factor in-duces differentiation of adult rat mesenchymal stem cells intoa hepatocyte lineage in vitro[J].Zhonghua Waike Zazhi, 2005, 43 (11) :716-720.
    • Relative Articles

  • Relative Articles

    [1]Zhang LiJun, Liu MingJun, Wang Shuai, Wang Lin, Wang RuKun, Hou HuaBin, Sun GuiRong, Zhang NaNa, Liu LinJie. Clinical value of Golgi protein 73 and hyaluronic acid in diagnosis of the progression of hepatitis B virus-related chronic liver diseases[J]. Journal of Clinical Hepatology, 2018, 34(1): 63-67. doi: 10.3969/j.issn.1001-5256.2018.01.013
    [2]Zhao DanTong, Liao HuiYu, Liu YanMin, Huang ChunYang, Zhang HaiPing, Sun LiMei, Ma YinXue, Zhao Yan, Yan HuiPing. ROC analysis of prognostic factors in Chinese patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(1): 62-66. doi: 10.3969/j.issn.1001-5256.2014.01.017
    [3]Jin HongHui, Li ZhongPing. Correlational research of serum ferritin and hyaluronic acid in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(3): 216-218.
    [4]Jin HongHui, Ding XiaoHong. ROC curve analysis of blood platelet and hyaluronic acid levels for diagnosing cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(6): 456-458.
    [5]Song ZuoLi, Liu ShuYe, Ding Xian. Assess the value of laboratory diagnosis index for alcoholic liver disease with ROC curve[J]. Journal of Clinical Hepatology, 2008, 24(5): 353-354.
    [7]Fan GongRen, Ren YongQiang, Cui Kun, Ji ShengJie, Deng Tao. The diagnosis value of hyaluronic acid, typeⅢprocollagen, type collagen and proline dipeptidase in liver fibrosis[J]. Journal of Clinical Hepatology, 2007, 23(1): 19-21.
    [9]Wei LiJing, Xu Wei, Wei LiQin, Niu ChunHui. Soluble intercellular adhesion molecule-1, Hyaluronic acid and their clinical signifieance in liver cirrhosis[J]. Journal of Clinical Hepatology, 2003, 19(4): 234-235.
    • Supplements(0)
    • Cited By
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 4.6 %FULLTEXT: 4.6 %META: 89.8 %META: 89.8 %PDF: 5.6 %PDF: 5.6 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 3.3 %其他: 3.3 %Sweden: 1.3 %Sweden: 1.3 %上海: 2.3 %上海: 2.3 %北京: 8.3 %北京: 8.3 %南宁: 0.3 %南宁: 0.3 %台州: 0.7 %台州: 0.7 %吉林: 0.7 %吉林: 0.7 %弗吉: 0.3 %弗吉: 0.3 %张家口: 4.0 %张家口: 4.0 %杭州: 0.7 %杭州: 0.7 %武汉: 1.7 %武汉: 1.7 %石家庄: 0.3 %石家庄: 0.3 %绵阳: 0.3 %绵阳: 0.3 %芒廷维尤: 37.6 %芒廷维尤: 37.6 %苏州: 0.3 %苏州: 0.3 %莫斯科: 1.3 %莫斯科: 1.3 %西宁: 34.7 %西宁: 34.7 %邯郸: 0.3 %邯郸: 0.3 %长春: 1.3 %长春: 1.3 %长沙: 0.3 %长沙: 0.3 %其他Sweden上海北京南宁台州吉林弗吉张家口杭州武汉石家庄绵阳芒廷维尤苏州莫斯科西宁邯郸长春长沙

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3131) PDF downloads(811) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2656]YesterdayPV[5814]TodayIP[336]TodayPV[476]Online[48]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return